Bowhead is a precision medicine company with several assets in development, including a portfolio of in-licensed therapeutics against bacterial infections, as well as in-house therapeutics for autoimmunity, cancer and viral infections. Our AI platform to transform clinical trial enrolment is an intelligent alternative to tedious manual screening, Bowhead Navigator uses transparent, auditable reasoning to instantly match patients with life-saving cancer trials. We are validating the platform with leading cancer centers and plan a global rollout in 2026. Through Bowhead Research Labs, our integrated wet lab tests AI predictions in vitro, creating a closed loop between discovery and patient care.